Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Dec;30(6):896-900.
doi: 10.1128/AAC.30.6.896.

Pharmacokinetics of ticarcillin and clavulanic acid (timentin) in relation to renal function

Pharmacokinetics of ticarcillin and clavulanic acid (timentin) in relation to renal function

G L Jungbluth et al. Antimicrob Agents Chemother. 1986 Dec.

Abstract

The disposition of coadministered ticarcillin (3 g/1.73 m2) and clavulanic acid (100 mg/1.73 m2) was examined after a 30-min infusion in 24 noninfected subjects with various degrees of renal function. Noncompartmental pharmacokinetic parameters for the individual compounds were determined from plasma concentrations and urinary excretion rates. All clearances (total, renal, and nonrenal) and urinary recoveries of unchanged drug were found to be linearly related to creatinine clearance (CLCR). The steady-state volume of distribution (9.9 and 12.9 liters for ticarcillin and clavulanic acid) approximated the extracellular fluid space and was not related to CLCR. The half-lives increased with reduced renal function and ranged from 56 to 392 min for ticarcillin and 26 to 266 min for clavulanic acid. The clearances of both drugs decreased proportionately with reduction in renal function, facilitating dosing adjustments based on CLCR. Calculations of expected steady-state maximum and minimum concentrations in plasma using constant doses and an extended dosing interval related to CLCR further rationalized use of the 30:1 drug combination ratio for all patients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Pharmacol Ther. 1975 Apr;17(4):441-6 - PubMed
    1. J Antimicrob Chemother. 1985 Dec;16(6):763-71 - PubMed
    1. J Infect Dis. 1976 Jan;133(1):46-9 - PubMed
    1. Life Sci. 1978 Apr 3-17;22(13-15):1305-60 - PubMed
    1. J Antimicrob Chemother. 1980 Jul;6(4):455-70 - PubMed

MeSH terms

LinkOut - more resources